Merck Earnings Estimate

MRK
 Stock
  

USD 92.64  0.22  0.24%   

Many public companies, such as Merck, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Merck's earnings estimates, investors can diagnose different trends across Merck's analyst sentiment over time as well as compare current estimates against different timeframes.
Merck is projected to generate 5.82 in earnings per share on the 31st of December 2021. Merck earnings estimates module stress-tests analyst consensus about projected Merck Company EPS (Earning Per Share) to derive its highest and lowest estimates based on its historical volatility. Additionally, see Stocks Correlation.
  
Refresh
The current Gross Profit is estimated to decrease to about 34.8 B. The current Profit Margin is estimated to decrease to 0.24
Share

Merck Earnings Estimation Breakdown

Calculation of earning per share of Merck Company is based on official Zacks consensus of 5 analysts regarding Merck future annual earnings. Given the historical accuracy of 82.77%, the future earnings per share of Merck is estimated to be 5.82 with the lowest and highest values of 5.65 and 5.98, respectively. Please note that this consensus of annual earnings estimates for Merck Company is an estimate of EPS before non-recurring items and including employee stock options expenses
  Current EPS 2.83
5.65
Lowest
Expected EPS 5.82
5.98
Highest

Merck Earnings Projection Consensus

Suppose the current estimates of Merck's value are higher than the current market price of the Merck stock. In this case, investors may conclude that Merck is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Merck's stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyCurrent EPSEPS Estimate for 31st of December 2021

5

82.77%

2.83

5.82

Merck Earnings History

Earnings estimate consensus by Merck Company analysts from Wall Street is used by the market to judge Merck's stock performance. The investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only Merck's upcoming profit reports and earnings-per-share forecasts but also compare them to our different valuation methods.

Merck Quarterly Earnings Before Interest Taxes and Depreciation Amortization EBITDA

5.98 Billion

Share
Merck Accumulated Retained Earnings Deficit are increasing as compared to previous years. The last year's value of Accumulated Retained Earnings Deficit was reported at 53.7 Billion. The current Price to Earnings Ratio is estimated to increase to 15.24, while Earning Before Interest and Taxes EBIT is projected to decrease to under 12.8 B. The current Weighted Average Shares Diluted is estimated to increase to about 3 B, while Weighted Average Shares is projected to decrease to under 2.5 B.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Merck's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Merck in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
90.9792.4193.85
Details
Intrinsic
Valuation
LowReal ValueHigh
83.3899.01100.45
Details
Naive
Forecast
LowNext ValueHigh
96.5898.0199.45
Details
17 Analysts
Consensus
LowTarget PriceHigh
70.0090.88110.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Merck. Your research has to be compared to or analyzed against Merck's peers to derive any actionable benefits. When done correctly, Merck's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Merck Company.
Note that many institutional investors and large investment bankers can move markets due to the volume of Merck assets they manage. They also follow analysts to some degree and often drive overall investor sentiments towards Merck. With so many stockholders watching consensus numbers, the difference between actual and projected earnings is one of the most critical factors driving Merck stock price in the short term.

Merck Earnings per Share Projection vs Actual

Actual Earning per Share of Merck refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Merck Company predict the company's earnings will be in the future. The higher the earnings per share of Merck, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Merck Estimated Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Merck, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Merck should always be considered in relation to other companies to make a more educated investment decision.

Merck Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact Merck's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2022-04-28
2022-03-311.832.140.3116 
2022-02-03
2021-12-311.531.80.2717 
2021-10-28
2021-09-301.55451.750.195512 
2021-07-29
2021-06-301.34841.31-0.0384
2021-04-29
2021-03-311.61351.4-0.213513 
2021-02-04
2020-12-311.3881.32-0.068
2020-10-27
2020-09-301.43421.740.305821 
2020-07-31
2020-06-301.08871.370.281325 
2020-04-28
2020-03-311.3421.50.15811 
2020-02-05
2019-12-311.14681.160.0132
2019-10-29
2019-09-301.24231.510.267721 
2019-07-30
2019-06-301.15841.30.141612 
2019-04-30
2019-03-311.05321.220.166815 
2019-02-01
2018-12-311.03361.040.0064
2018-10-25
2018-09-301.14091.190.0491
2018-07-27
2018-06-301.03081.060.0292
2018-05-01
2018-03-310.99561.050.0544
2018-02-02
2017-12-310.93570.980.0443
2017-10-27
2017-09-301.03161.110.0784
2017-07-28
2017-06-300.87471.010.135315 
2017-05-02
2017-03-310.83120.880.0488
2017-02-02
2016-12-310.88880.890.0012
2016-10-25
2016-09-300.98891.070.0811
2016-07-29
2016-06-300.91050.930.0195
2016-05-05
2016-03-310.85110.890.0389
2016-02-03
2015-12-310.91230.930.0177
2015-10-27
2015-09-300.920.960.04
2015-07-28
2015-06-300.810.860.05
2015-04-28
2015-03-310.750.850.113 
2015-02-04
2014-12-310.860.870.01
2014-10-27
2014-09-300.880.90.02
2014-07-29
2014-06-300.810.850.04
2014-04-29
2014-03-310.790.880.0911 
2014-02-05
2013-12-310.890.88-0.01
2013-10-28
2013-09-300.880.920.04
2013-07-30
2013-06-300.830.840.01
2013-05-01
2013-03-310.790.850.06
2013-02-01
2012-12-310.810.830.02
2012-10-26
2012-09-300.920.950.03
2012-07-27
2012-06-301.011.050.04
2012-04-27
2012-03-31None0.5647None
2012-02-02
2011-12-310.950.970.02
2011-10-28
2011-09-300.910.940.03
2011-07-29
2011-06-300.950.950
2011-04-29
2011-03-310.840.920.08
2011-02-03
2010-12-310.830.880.05
2010-10-29
2010-09-300.820.850.03
2010-07-30
2010-06-300.830.860.03
2010-05-04
2010-03-310.750.830.0810 
2010-02-16
2009-12-310.790.790
2009-10-22
2009-09-300.820.90.08
2009-07-21
2009-06-300.770.830.06
2009-04-21
2009-03-310.770.74-0.03
2009-02-03
2008-12-310.740.870.1317 
2008-10-22
2008-09-300.790.80.01
2008-07-21
2008-06-300.830.860.03
2008-04-21
2008-03-310.860.890.03
2008-01-30
2007-12-310.740.80.06
2007-10-22
2007-09-300.690.750.06
2007-07-23
2007-06-300.720.820.113 
2007-04-19
2007-03-310.840.840
2007-01-30
2006-12-310.50.50
2006-10-20
2006-09-300.50.510.01
2006-07-24
2006-06-300.650.730.0812 
2006-04-20
2006-03-310.720.780.06
2006-01-31
2005-12-310.620.640.02
2005-10-24
2005-09-300.620.650.03
2005-07-21
2005-06-300.620.620
2005-04-21
2005-03-310.590.620.03
2005-01-25
2004-12-310.50.50
2004-10-21
2004-09-300.710.6-0.1115 
2004-07-21
2004-06-300.790.790
2004-04-22
2004-03-310.720.730.01
2004-01-27
2003-12-310.620.620
2003-10-22
2003-09-300.850.83-0.02
2003-07-21
2003-06-300.840.83-0.01
2003-04-21
2003-03-310.760.760
2003-01-28
2002-12-310.830.830
2002-10-18
2002-09-300.830.830
2002-07-19
2002-06-300.770.770
2002-04-18
2002-03-310.710.710
2002-01-22
2001-12-310.80.810.01
2001-10-18
2001-09-300.830.840.01
2001-07-20
2001-06-300.780.780
2001-04-20
2001-03-310.710.710
2001-01-23
2000-12-310.750.750
2000-10-20
2000-09-300.730.780.05
2000-07-24
2000-06-300.690.730.04
2000-04-24
2000-03-310.620.630.01
2000-01-26
1999-12-310.660.660
1999-10-21
1999-09-300.640.640
1999-07-23
1999-06-300.610.610
1999-04-23
1999-03-310.540.550.01
1999-01-26
1998-12-310.580.580
1998-10-16
1998-09-300.560.560
1998-07-21
1998-06-300.540.560.02
1998-04-16
1998-03-310.480.480
1998-01-27
1997-12-310.510.520.01
1997-10-16
1997-09-300.50.50
1997-07-17
1997-06-300.480.480
1997-04-16
1997-03-310.420.420
1997-01-28
1996-12-310.430.440.01
1996-10-16
1996-09-300.410.420.01
1996-07-18
1996-06-300.40.40
1996-04-17
1996-03-310.350.350

About Merck Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Merck earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Merck estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Merck fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for 2022
Accumulated Retained Earnings Deficit53.7 B53.8 B
Earning Before Interest and Taxes EBIT14.6 B12.8 B
Earnings per Basic Share 5.16  4.17 
Earnings per Diluted Share 5.14  4.15 
Price to Earnings Ratio 14.85  15.24 
Earnings Before Interest Taxes and Depreciation Amortization EBITDA17.8 B15.4 B
Earnings before Tax14.6 B12.8 B
Merck Co., Inc. operates as a healthcare company worldwide. Merck Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey. Merck operates under Drug ManufacturersGeneral classification in the United States and is traded on New York Stock Exchange. It employs 67000 people.

Merck Investors Sentiment

The influence of Merck's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Merck. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.
Investor biases related to Merck's public news can be used to forecast risks associated with investment in Merck. The trend in average sentiment can be used to explain how an investor holding Merck can time the market purely based on public headlines and social activities around Merck Company. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
Merck's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Merck's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Merck's news discussions. The higher the estimate score, the more favorable is the investor's outlook on Merck.

Merck Implied Volatility

    
  26.0  
Merck's implied volatility exposes the market's sentiment of Merck Company stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Merck's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Merck stock will not fluctuate a lot when Merck's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Merck in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Merck's short interest history, or implied volatility extrapolated from Merck options trading.

Current Sentiment - MRK

Merck Company Investor Sentiment

Predominant part of Macroaxis users are now bullish on Merck Company. What is your trading attitude regarding investing in Merck Company? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Merck Company using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Additionally, see Stocks Correlation. Note that the Merck Company information on this page should be used as a complementary analysis to other Merck's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Complementary Tools for Merck Stock analysis

When running Merck Company price analysis, check to measure Merck's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merck is operating at the current time. Most of Merck's value examination focuses on studying past and present price action to predict the probability of Merck's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Merck's price. Additionally, you may evaluate how the addition of Merck to your portfolios can decrease your overall portfolio volatility.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Is Merck's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Merck. If investors know Merck will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Merck listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
0.36
Market Capitalization
233.7 B
Quarterly Revenue Growth YOY
0.5
Return On Assets
0.12
Return On Equity
0.41
The market value of Merck Company is measured differently than its book value, which is the value of Merck that is recorded on the company's balance sheet. Investors also form their own opinion of Merck's value that differs from its market value or its book value, called intrinsic value, which is Merck's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Merck's market value can be influenced by many factors that don't directly affect Merck's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Merck's value and its price as these two are different measures arrived at by different means. Investors typically determine Merck value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Merck's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.